key: cord-0696731-fdoo17kj
authors: Lechien, Jerome R.; Saussez, Sven; Vaira, Luigi A.; Hans, Stephane
title: Post-COVID-19 Dysphonia may have Several Origins
date: 2021-10-28
journal: Indian J Otolaryngol Head Neck Surg
DOI: 10.1007/s12070-021-02951-9
sha: 1e37a359da222d2689f9b0fd07bcbe3140b9907b
doc_id: 696731
cord_uid: fdoo17kj

nan

research. However, we wish to draw attention to many points.

First, as reported in other studies [2, 3] , COVID-19 may be associated with dysphonia and the study of Aziz Azzam et al. supports the association. An important confounding factor that was not evaluated by authors is the prevalence of laryngopharyngeal reflux (LPR) in the cohort. The prevalence of LPR in North Africa was estimated to 19.2% [4] . LPR is associated with similar otolaryngological nonspecific symptoms than COVID-19, including cough, postnasal drip, throat clearing, throat pain, and dysphonia [4] . From a clinical standpoint, LPR is associated with vocal fold findings, swelling, ventricular and laryngeal edema [4] ; all of them being observed by Aziz Azzam et al. in the study population. The consideration of LPR is important in a pandemic period because the increased stress and anxiety of patient related to COVID-19 infection may have favored autonomic nerve dysfunction, which is associated with esophageal sphincter relaxations and, therefore, an increase of pharyngeal reflux events [5] . Interestingly, females are more susceptible to develop dysphonia related to LPR [6] , which may corroborate the observation of Aziz Azzam et al. The increase of LPR prevalence in the context of COVID-19 pandemic was moreover suggested in a previous study [7] .

Second, the use of inhaled corticosteroids is another confounding factor that may be associated with dysphonia. Inhaled corticosteroids may be particularly prescribed in patients with mild COVID-19 and dyspnea. The consideration of inhaled corticosteroids makes sense because they may lead to vocal fold dryness and dysphonia [8] .

Third, authors observed vocal fold immobility in 13.2% of patients. This observation is particularly important because severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to be a neurotropic virus, and was associated with some nerve disorders, i.e. vocal fold paradoxical movement, olfactory dysfunction, and sudden hearing loss [9, 10] . The prevalence of laryngeal nerve impairments in COVID-19 population is probably underestimated because, in practice, few dysphonic patients really benefited from videolaryngostroboscopical examination. This association has to be investigated in future large multicenter studies.

We congratulate Aziz Azzam et al. for this interesting study that highlights the importance of dysphonia in COVID-19. Future studies are needed to reinforce the prevalence of dysphonia in COVID-19 patients considering direct and indirect mechanisms such as LPR or inhaled corticosteroids.

Funding No funding.

Conflict of interest The authors declare that they do not have any conflict of interest.

Vocal Disorders in Patients with COVID 19 in Egypt

Prevalence of Dysphonia in Non hospitalized Patients with COVID-19 in Lombardy, the Italian Epicenter of the Pandemic

Features of Mild-to-Moderate COVID-19 Patients With Dysphonia

Management of Laryngopharyngeal Reflux Around the World: An International Study

Association between laryngopharyngeal reflux disease and autonomic nerve dysfunction

Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study

The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study

Inhaled Corticosteroids and Voice Problems What Is New? J Voice

Post-COVID-19 paradoxical vocal fold movement disorder

Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations